Raymond expands Andhra Pradesh manufacturing with a new brownfield facility while Jubilant Pharmova secures board approval to raise Rs 800 crore.
Corporate updates on October 12, 2026, show major strategic moves from Raymond and Jubilant Pharmova as both firms adjust their capital and manufacturing footprints.
Raymond Targets Immediate Growth in Andhra Pradesh
Raymond is accelerating its manufacturing capacity through its subsidiary companies in Andhra Pradesh to support strong business momentum and growing customer requirements.
- Strategic priority: Building an interim brownfield facility near the existing Mega manufacturing plant.
- Timeline focus: Designed to handle incremental customer volumes and requirements during the current financial year.
- Long-term outlook: Planned greenfield project in the same state continues to progress as scheduled to enhance future infrastructure.
The company is concentrating heavily on its Engineering sectors, which cover Tools and Hardware, Auto Components, and Precision tools.
Jubilant Pharmova Moves on Debt Issuance
In parallel developments, the board of Jubilant Pharmova has taken significant steps regarding capital raising and debt management.
- Rs 800 crore: Approved amount to be raised through the issuance of Non-Convertible Debentures via private placement.
- Rs 2,500 crore: Proposed umbrella limit for borrowing via debt securities over the next year, subject to shareholder approval.
These capital initiatives provide both organizations with specific operational adjustments to handle near-term market demands and medium-term strategic scaling.
